{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:55:41Z","timestamp":1793246141497,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Percutaneous endoscopic gastrostomy (PEG) is often used to provide nutritional support in locally advanced head and neck cancer patients undergoing multimodality treatment. However, there is little published data on the impact of prophylactic versus reactive PEG. PEG placement may affect swallowing-related physiology, function, and quality of life. The Swall PEG study is a randomized controlled phase III trial testing the impact of prophylactic versus reactive PEG on patient-reported outcomes in terms of swallowing and quality of life in oropharyngeal cancer patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with locally advanced oropharyngeal cancer receiving chemo-radiotherapy will be randomized to either the prophylactic or reactive PEG tube group. Randomization will be stratified by human papillomavirus (HPV) status and unilateral versus bilateral positive neck lymph nodes. The primary objective of the study is the patient\u2019s reported outcome in terms of swallowing (MD Anderson Dysphagia Inventory (MDADI)) at 6 months. Secondary objectives include health-related quality of life, dosimetric parameters associated with patient-reported outcomes, chemo-radiation toxicities, PEG tube placement complications, the impact of nutritional status on survival and toxicity outcomes, loco-regional control, overall survival, the impact of HPV and tobacco smoking on survival outcomes and toxicities, and the cost-effectiveness of each treatment strategy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Findings from this study will enhance clinical evidence regarding nutritional management in oropharyngeal cancer patients treated by concurrent chemo-radiation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link> NCT04019548, study protocol version 2.0_08\/08\/2019. Registered on 15 July 2019<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06991-6","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:03:47Z","timestamp":1671588227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3406-1683","authenticated-orcid":false,"given":"Tatiana","family":"Dragan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Van Gossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Duprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Lalami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolene","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiana","family":"Mootassim-Billah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Beauvois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akos","family":"Gulyban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vandekerkhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Boegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Paesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieveke","family":"Ameye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Digonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Quiriny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Dequanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Lipski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Willemse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Carlot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lemort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Emonts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Al Wardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Van Gestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"6991_CR1","unstructured":"Global Cancer Observatory. [cited 2021 Mar 22]. Available from: https:\/\/gco.iarc.fr\/."},{"key":"6991_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"J-P Pignon","year":"2009","unstructured":"Pignon J-P, le Ma\u00eetre A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4\u201314 [cited 2018 Apr 12]; Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814009001881.","journal-title":"Radiother Oncol"},{"key":"6991_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0360-3016(96)00430-0","volume":"36","author":"JM Bachaud","year":"1996","unstructured":"Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996;36:999\u20131004 [cited 2018 Apr 12];Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8985019.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6991_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"J Bernier","year":"2004","unstructured":"Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lef\u00e8bvre J-L, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945\u201352 [cited 2018 Feb 19];Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15128894.","journal-title":"N Engl J Med"},{"key":"6991_CR5","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa032646","volume":"350","author":"JS Cooper","year":"2004","unstructured":"Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937\u201344 [cited 2018 Apr 27]; Available from: http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa032646.","journal-title":"N Engl J Med"},{"key":"6991_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/hed.20279","volume":"27","author":"J Bernier","year":"2005","unstructured":"Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27:843\u201350 [cited 2018 30]; Available from: http:\/\/doi.wiley.com\/10.1002\/hed.20279.","journal-title":"Head Neck"},{"key":"6991_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, Wagner H, Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92\u20138 [cited 2019 Jun 19]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12506176.","journal-title":"J Clin Oncol"},{"key":"6991_CR8","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa031317","volume":"349","author":"AA Forastiere","year":"2003","unstructured":"Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091\u20138 [cited 2019 Jun 19];Available from: http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa031317.","journal-title":"N Engl J Med"},{"key":"6991_CR9","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","volume":"26","author":"M Machtay","year":"2008","unstructured":"Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol. 2008;26:3582\u20139 [cited 2018 Feb 19]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18559875.","journal-title":"J Clin Oncol"},{"key":"6991_CR10","first-page":"425","volume":"37","author":"MK Wax","year":"2015","unstructured":"Wax MK, Ringash J, Bernstein LJ, Cella D, Logemann J, Movsas B, et al. CLINICAL REVIEW Outcomes toolbox for head and neck cancer research. Wiley Period Inc Head Neck. 2015;37:425\u201339.","journal-title":"Wiley Period Inc Head Neck"},{"key":"6991_CR11","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1200\/JCO.2007.12.4784","volume":"25","author":"A Trotti","year":"2007","unstructured":"Trotti A, Colevas AD, Setser A. Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol. 2007;25:5121\u20137 [cited 2018 Apr 12]; Available from: http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2007.12.4784.","journal-title":"J Clin Oncol"},{"key":"6991_CR12","doi-asserted-by":"publisher","DOI":"10.2307\/j.ctt1xp3vbc","volume-title":"Clinimetrics [Internet]","author":"AR Feinstein","year":"1987","unstructured":"Feinstein AR. Clinimetrics [Internet]: Yale University Press; 1987. [cited 2018 Apr 27]. Available from: https:\/\/books.google.be\/books\/about\/Clinimetrics.html?id=P6iDQgAACAAJ&redir_esc=y."},{"key":"6991_CR13","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1200\/JCO.1999.17.3.1008","volume":"17","author":"K Bjordal","year":"1999","unstructured":"Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999;17:1008 [cited 2018 Apr 12]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10071296.","journal-title":"J Clin Oncol"},{"key":"6991_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/hed.23127","volume":"35","author":"S Singer","year":"2013","unstructured":"Singer S, Arraras JI, Baumann I, Boehm A, Chie W-C, Galalae R, et al. Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy--update of the EORTC QLQ-H&N35, Phase I. Head Neck. 2013;35:1331\u20138 [cited 2018 Apr 12]; Available from: http:\/\/doi.wiley.com\/10.1002\/hed.23127.","journal-title":"Head Neck"},{"key":"6991_CR15","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s11136-012-0325-1","volume":"22","author":"S Singer","year":"2013","unstructured":"Singer S, Arraras JI, Chie W-C, Fisher SE, Galalae R, Hammerlid E, et al. Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review. Qual Life Res. 2013;22:1927\u201341 [cited 2018 Apr 12]; Available from: http:\/\/link.springer.com\/10.1007\/s11136-012-0325-1.","journal-title":"Qual Life Res"},{"key":"6991_CR16","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/hed.25609","volume":"41","author":"S Singer","year":"2019","unstructured":"Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, et al. International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Head Neck. 2019;41:1725\u201337 [cited 2021 Mar 22]; Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/hed.25609.","journal-title":"Head Neck"},{"key":"6991_CR17","first-page":"870","volume":"127","author":"AY Chen","year":"2001","unstructured":"Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg. 2001;127:870\u20136 [cited 2018 Apr 27]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11448365.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"6991_CR18","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1200\/JCO.2007.14.6647","volume":"26","author":"JA Langendijk","year":"2008","unstructured":"Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol. 2008;26:3770\u20136 [cited 2020 May 3]; Available from: http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2007.14.6647.","journal-title":"J Clin Oncol"},{"key":"6991_CR19","doi-asserted-by":"publisher","unstructured":"Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN Guideline ESPEN guidelines on nutrition in cancer patients *. 2016 [cited 2021 Apr 15]; Available from:. https:\/\/doi.org\/10.1016\/j.clnu.2016.07.015.","DOI":"10.1016\/j.clnu.2016.07.015"},{"key":"6991_CR20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3748\/wjg.v17.i8.1004","volume":"17","author":"MF Madhoun","year":"2011","unstructured":"Madhoun MF, Blankenship MM, Blankenship DM, Krempl GA, Tierney WM. Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)? World J Gastroenterol. 2011;17:1004\u20138 [cited 2018 Feb 19]; Available from: http:\/\/www.wjgnet.com\/1007-9327\/full\/v17\/i8\/1004.htm.","journal-title":"World J Gastroenterol"},{"key":"6991_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00455-014-9592-z","volume":"30","author":"SM Shaw","year":"2015","unstructured":"Shaw SM, Flowers H, O\u2019Sullivan B, Hope A, Liu LWC, Martino R. The effect of prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement on swallowing and swallow-related outcomes in patients undergoing radiotherapy for head and neck cancer: a systematic review. Dysphagia. 2015;30:152\u201375 [cited 2018 Jul 6]; Available from: http:\/\/link.springer.com\/10.1007\/s00455-014-9592-z.","journal-title":"Dysphagia"},{"key":"6991_CR22","doi-asserted-by":"publisher","unstructured":"Dragan T, Duprez F, Van GA, Beauvois S, Digonnet A, Lalami Y, et al. Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists. 2020 [cited 2021 Mar 22]. https:\/\/doi.org\/10.21203\/rs.3.rs-70709\/v1.","DOI":"10.21203\/rs.3.rs-70709\/v1"},{"key":"6991_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clon.2010.01.008","volume":"22","author":"JW Moor","year":"2010","unstructured":"Moor JW, Patterson J, Kelly C, Paleri V. Prophylactic gastrostomy before chemoradiation in advanced head and neck cancer: a multiprofessional web-based survey to identify current practice and to analyse decision making. Clin Oncol. 2010;22:192\u20138 [cited 2018 Aug 1]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0936655510000452?via%3Dihub.","journal-title":"Clin Oncol"},{"key":"6991_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00455-011-9375-8","volume":"27","author":"S Carlsson","year":"2012","unstructured":"Carlsson S, Ryd\u00e9n A, Rudberg I, Bove M, Bergquist H, Finizia C. Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer and neurologic swallowing disturbances. Dysphagia. 2012;27:361\u20139 [cited 2018 Jul 10]; Available from: http:\/\/link.springer.com\/10.1007\/s00455-011-9375-8.","journal-title":"Dysphagia"},{"key":"6991_CR25","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/lary.25778","volume":"126","author":"KA Hutcheson","year":"2016","unstructured":"Hutcheson KA, Barrow MP, Lisec A, Barringer DA, Gries K, Lewin JS. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients? Laryngoscope. 2016;126:1108\u201313 [cited 2018 Jul 11]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26542529.","journal-title":"Laryngoscope"},{"key":"6991_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","volume":"38","author":"T Cederholm","year":"2019","unstructured":"Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition \u2013 a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38:1\u20139 [cited 2021 Mar 22]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30181091\/.","journal-title":"Clin Nutr"},{"key":"6991_CR27","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.18.00684","volume":"36","author":"C Fakhry","year":"2018","unstructured":"Fakhry C, Lacchetti C, Rooper LM, Jordan RC, Rischin D, Sturgis EM, et al. Human papillomavirus testing in head and neck carcinomas: ASCO clinical practice guideline endorsement of the college of American pathologists guideline. J Clin Oncol. 2018;36:3152\u201361.","journal-title":"J Clin Oncol"},{"key":"6991_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","volume":"134","author":"J Biau","year":"2019","unstructured":"Biau J, Lapeyre M, Troussier I, Budach W, Giralt J, Grau C, et al. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiother Oncol. 2019;134:1\u20139. [cited 2019 Jun 19]; Available from:. https:\/\/doi.org\/10.1016\/j.radonc.2019.01.018.","journal-title":"Radiother Oncol"},{"key":"6991_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"V Gr\u00e9goire","year":"2018","unstructured":"Gr\u00e9goire V, Evans M, Le Q-T, Bourhis J, Budach V, Chen A, et al. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol. 2018;126:3\u201324 [cited 2018 Apr 27]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0167814017326567?via%3Dihub.","journal-title":"Radiother Oncol"},{"key":"6991_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","volume":"117","author":"CL Brouwer","year":"2015","unstructured":"Brouwer CL, Steenbakkers RJHM, Bourhis J, Budach W, Grau C, Gr\u00e9goire V, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol. 2015;117:83\u201390 [cited 2019 Jun 15]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0167814015004016.","journal-title":"Radiother Oncol"},{"key":"6991_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.radonc.2011.05.015","volume":"101","author":"MEMC Christianen","year":"2011","unstructured":"Christianen MEMC, Langendijk JA, Westerlaan HE, van de Water TA, Bijl HP. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol. 2011;101:394\u2013402 [cited 2019 Feb 14]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0167814011002076.","journal-title":"Radiother Oncol"},{"key":"6991_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341\u20136 [cited 2018 Apr 12]; Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/036030169500060C.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6991_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347 [cited 2018 Feb 19]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19097774.","journal-title":"Eur J Cancer"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06991-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06991-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06991-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:04:38Z","timestamp":1671588278000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06991-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6991"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06991-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"30 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Jules Bordet Hospital Ethics Committee (Swall PEG; IJB-RT-HNC-001). All patients will be informed by the study investigators and included after providing written consent. The informed consent form is based on the Belgian national template and is identified by a version number and a date, and it makes reference to the associated protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1036"}}